NCT04872764

Brief Summary

We aimed to investigate the effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 2, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 4, 2021

Completed
Last Updated

May 4, 2021

Status Verified

May 1, 2021

Enrollment Period

8 months

First QC Date

May 2, 2021

Last Update Submit

May 2, 2021

Conditions

Covid19Acute Kidney Injury

Outcome Measures

Primary Outcomes (2)

  • mortality rate

    mortality rates of COVID-19 patients with and without Acute Kidney Injury

    6 months

  • duration of hospitalisation

    time between admission to hospital and discharge for COVID-19 patients with and without Acute Kidney Injury

    6 months

Study Arms (2)

COVID-19 patients with acute kidney injury

COVID-19 patients with acute kidney injury

Other: duration of hospitalization, mortality rate

COVID-19 patients without acute kidney injury

COVID-19 patients without acute kidney injury

Other: duration of hospitalization, mortality rate

Interventions

duration of hospitalization, mortality rateOTHER

duration of hospitalization, mortality rates of patients hospitalised for COVID-19 evaluated and compared in patients with and without acute kidney injury.

COVID-19 patients with acute kidney injuryCOVID-19 patients without acute kidney injury

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients hospitalised for COVID-19 with and without acute kidney injury

You may qualify if:

  • Patients hospitalised with COVID-19.
  • Patients hospitalised with COVID-19 with Acute Kidney Injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Usak University

Uşak, 64100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19Acute Kidney Injury

Interventions

Mortality

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Vital StatisticsData CollectionEpidemiologic MethodsInvestigative TechniquesDemographyPopulation CharacteristicsEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Zelal Adibelli

    Uşak University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asistant Professor

Study Record Dates

First Submitted

May 2, 2021

First Posted

May 4, 2021

Study Start

March 20, 2020

Primary Completion

November 20, 2020

Study Completion

December 20, 2020

Last Updated

May 4, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)